Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis

Amir Haddad,1 Nili Stein,2 Idit Lavi,2 Lisa Shynkar,3 Irina Bergman,3,4 Ilan Feldhamer,5 Arnon Dov Cohen,5,6 Walid Saliba,2,4 Devy Zisman1,4 1Rheumatology Unit, Carmel Medical Center, Haifa, Israel; 2Department of Epidemiology, Clalit Health Services, Haifa, Israel; 3Internal Medicine Department, Ca...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Haddad A, Stein N, Lavi I, Shynkar L, Bergman I, Feldhamer I, Cohen AD, Saliba W, Zisman D
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Dove Medical Press 2023-10-01
Saila:Biologics: Targets & Therapy
Gaiak:
psoriatic arthritis
drug persistence
therapy
apremilast
Sarrera elektronikoa:https://www.dovepress.com/treatment-persistence-of-apremilast-among-patients-with-psoriatic-arth-peer-reviewed-fulltext-article-BTT

Internet

https://www.dovepress.com/treatment-persistence-of-apremilast-among-patients-with-psoriatic-arth-peer-reviewed-fulltext-article-BTT

Antzeko izenburuak